Noroviruses: State of the Art

被引:91
作者
Atmar, Robert L. [1 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Norovirus; Gastroenteritis; Review; Human; Calicivirus; NORWALK VIRUS-INFECTION; CELLULAR IMMUNE-RESPONSES; BLOOD GROUP ANTIGENS; ACUTE GASTROENTERITIS; SRSV GASTROENTERITIS; UNITED-STATES; SNOW-MOUNTAIN; OUTBREAK; EPIDEMIOLOGY; RESISTANCE;
D O I
10.1007/s12560-010-9038-1
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Noroviruses are a common cause of both endemic and epidemic gastroenteritis. These highly infectious viruses usually cause self-limited disease, but chronic infections occur in highly immunocompromised patients and unusual manifestations are also being described in some populations. Histoblood-group antigen expression is now recognized as an important susceptibility factor for many norovirus strains, but a correlate of acquired immunity to infection or illness has not yet been identified. Currently, treatment and prevention strategies rely on nonspecific measures. However, virus-like particles containing capsid antigens are undergoing evaluation as a vaccine candidate for illness prevention. This article reviews the biologic properties, epidemiology, clinical features, host susceptibility, diagnosis, and treatment and prevention of norovirus infection.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 90 条
[1]  
Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842
[2]  
[Anonymous], 2002, MMWR-MORBID MORTAL W, V51, P477
[3]   Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses [J].
Atmar, RL ;
Estes, MK .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (01) :15-+
[4]   Norwalk virus shedding after experimental human infection [J].
Atmar, Robert L. ;
Opekun, Antone R. ;
Gilger, Mark A. ;
Estes, Mary K. ;
Crawford, Sue E. ;
Neill, Frederick H. ;
Graham, David Y. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (10) :1553-1557
[5]   The epidemiologic and clinical impartance of norovirus infection [J].
Atmar, Robert L. ;
Estes, Mary K. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (02) :275-+
[6]   Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study [J].
Ball, JM ;
Graham, DY ;
Opekun, AR ;
Gilger, MA ;
Guerrero, RA ;
Estes, MK .
GASTROENTEROLOGY, 1999, 117 (01) :40-48
[7]   Norovirus recombination [J].
Bull, Rowena A. ;
Tanaka, Mark M. ;
White, Peter A. .
JOURNAL OF GENERAL VIROLOGY, 2007, 88 :3347-3359
[8]   Cruise Ship Environmental Hygiene and the Risk of Norovirus Infection Outbreaks: An Objective Assessment of 56 Vessels over 3 Years [J].
Carling, Philip C. ;
Bruno-Murtha, Lou Ann ;
Griffiths, Jeffrey K. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) :1312-1317
[9]   The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection [J].
Carlsson, Beatrice ;
Kindberg, Elin ;
Buesa, Javier ;
Rydell, Gustaf E. ;
Lidon, Marta Fos ;
Montava, Rebeca ;
Abu Mallouh, Reem ;
Grahn, Ammi ;
Rodriguez-Diaz, Jesus ;
Bellido, Juan ;
Arnedo, Alberto ;
Larson, Goran ;
Svensson, Lennart .
PLOS ONE, 2009, 4 (05)
[10]   Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells [J].
Chang, Kyeong-Ok ;
George, David W. .
JOURNAL OF VIROLOGY, 2007, 81 (22) :12111-12118